首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   524篇
  免费   30篇
  国内免费   7篇
耳鼻咽喉   1篇
儿科学   7篇
妇产科学   4篇
基础医学   54篇
口腔科学   5篇
临床医学   86篇
内科学   78篇
皮肤病学   9篇
神经病学   30篇
特种医学   159篇
外科学   54篇
综合类   5篇
预防医学   18篇
眼科学   2篇
药学   37篇
肿瘤学   12篇
  2021年   2篇
  2020年   3篇
  2018年   9篇
  2016年   2篇
  2015年   5篇
  2014年   4篇
  2013年   9篇
  2012年   2篇
  2011年   11篇
  2010年   8篇
  2009年   10篇
  2008年   12篇
  2007年   12篇
  2006年   19篇
  2005年   15篇
  2004年   5篇
  2003年   7篇
  2002年   8篇
  2001年   11篇
  2000年   8篇
  1999年   12篇
  1998年   18篇
  1997年   29篇
  1996年   25篇
  1995年   18篇
  1994年   26篇
  1993年   18篇
  1992年   22篇
  1991年   21篇
  1990年   14篇
  1989年   26篇
  1988年   21篇
  1987年   12篇
  1986年   24篇
  1985年   16篇
  1984年   15篇
  1983年   5篇
  1982年   13篇
  1981年   6篇
  1980年   6篇
  1979年   3篇
  1978年   7篇
  1977年   9篇
  1976年   8篇
  1975年   7篇
  1971年   5篇
  1970年   4篇
  1966年   1篇
  1961年   1篇
  1935年   1篇
排序方式: 共有561条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
Glenohumeral joint: comparison of shoulder positions at MR arthrography   总被引:3,自引:0,他引:3  
Kwak  SM; Brown  RR; Trudell  D; Resnick  D 《Radiology》1998,208(2):375
  相似文献   
95.
IL-10 has a protective role in experimental autoimmune uveoretinitis   总被引:8,自引:0,他引:8  
The role of IL-10 in the regulation of ocular autoimmune disease was studied in experimental autoimmune uveoretinitis (EAU) elicited in mice by immunization with the retinal antigen interphotoreceptor retinoid binding protein. IL-10-deficient mice were susceptible to EAU, indicating that pathogenesis can occur without presence of IL-10. Treatment of normal mice with IL-10 for 5 days after uveitogenic immunization ameliorated subsequent EAU scores, and down-regulated antigen-specific production of tumor necrosis factor-alpha and IFN- gamma. A concomitant treatment with IL-4 further reduced disease, and resulted in emergence of antigen-specific IL-4 and IL-10 production, as well as in enhancement of the IgG1 antibody isotype. IL-4 by itself was not protective. Only IL-10, but not IL-4, was able to inhibit the function of differentiated uveitogenic T cells in culture. Expression of mRNA for Th1 and Th2 cytokines in the eye during the course of EAU showed that while a Th1 pattern predominated early, IL-10 mRNA expression coincided with down-regulation of the Th1 response and resolution of EAU. Systemic neutralization of IL-10 during the expression phase of EAU resulted in elevated disease scores. Our results suggest that endogenous IL-10 limits expression of EAU and may play a role in the natural resolution of disease. The data further suggest that exogenous IL-10 may be useful in therapeutic control of autoimmune uveitis. While IL-10 by itself is sufficient to suppress Th1 effector development and function, a concomitant administration of IL-4 is required to shift the autoimmune response towards a non-pathogenic Th2 pathway.   相似文献   
96.
Life expectancy in British Marfan syndrome populations   总被引:2,自引:0,他引:2  
A total of 206 patients with Marfan syndrome were ascertained throughout genetic clinics in Wales and Scotland during the period 1970–1990. There were 45 deaths representing 22% of the cohort. Mean age at death was 45.3 ± 16.5 years. 50% median cumulative survival in the total cohort (n = 206) was 53 years for males and 72 years for females. Multivariate analysis confirmed severity as the best independent indicator of survival. These findings and survival curves will assist in the counselling of British families and individuals with Marfan syndrome.  相似文献   
97.
98.
Postherpetic neuralgia is defined as pain persisting, or recurring, at the site of shingles at least three months after the onset of the acute rash. Thus defined, at least half of shingles sufferers over the age of 65 years develop postherpetic neuralgia. In addition to increasing age, less important risk factors for postherpetic neuralgia are pain severity of acute shingles and trigeminal distribution. Postherpetic neuralgia accounts for 11-15% of all referrals to pain clinics and would, in fact, be far more effectively dealt with in primary care. Effective treatment of acute shingles by systemic antivirals at the appropriate time may have some effect in reducing the incidence of postherpetic neuralgia, making it easier to treat with tricyclics and greatly reducing scarring (25% of all cases affect the face). Pre-emptive treatment with low-dose tricyclics (ami- or nor-triptyline 10-25 mg nocte) from the time of diagnosis of acute shingles reduces the incidence of postherpetic neuralgia by about 50%. Established postherpetic neuralgia should be vigorously treated with adrenergically active tricyclics in a dose rising over two or three weeks from 10-25 mg to 50-75 mg. Positive relaxation should also be used. Carbamazepine, like conventional analgesics, is of little or no value. Failure of tricyclics to effect relief within eight weeks calls for specialist treatment. North American practitioners in particular believe that some opioids (e.g., oxycodone) may be helpful in otherwise intractable cases.  相似文献   
99.
A competitive particle concentration fluorescence immunoassay (PCFIA) is described for measuring 5,10-dideaza-5,6,7,8-tetrahydrofolic acid (lometrexol; Lilly) in human serum. b-Phycoerythrin-labeled lometrexol competes with free lometrexol for binding to a limiting concentration of lometrexol-specific antibodies immobilized by a second antibody to submicrometer-diameter polystyrene particles in specially designed 96-well plates. Reaction particles are washed and concentrated onto filter membranes in the wells of the plates and the fluorescence is measured at 575 nm. The method, including sample preparation and data reduction, is automated and can be completed in less than 2 h. The assay has a standard curve maximum measurable concentration of 1000 micrograms/L and a minimum detectable concentration of 0.1 microgram/L. Analytical recovery of lometrexol in serum is quantitative at concentrations greater than 1 micrograms/L. Intra- and interassay coefficients of variation at 50 micrograms/L in serum are 7.1% (n = 9) and 7.5% (n = 33), respectively. The cross-reactivity of naturally occurring folates, folic acid analogs, and the anti-cancer agent methotrexate is minimal. We report the use of the PCFIA during Phase I clinical studies designed to evaluate the pharmacokinetics of lomextrexol after intravenous administration to cancer patients.  相似文献   
100.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号